YY1 and cancer: Similar to the diverging roles of YY1 during healthy tissue development, also in cancer YY1 has been found to act as either transcriptional activator or inhibitor and its overall impact on malignant tissues can be pro-as well as anti-tumorigenic (Sarvagalla et al., 2019).